Clinuvel Pharmaceuticals Ltd
(NAS:CUVL)
$
6.52
+0.33 (+5.33%)
Market Cap: 328.80 Mil
Enterprise Value: 148.69 Mil
PE Ratio: 12.20
PB Ratio: 1.51
GF Score: 82/100 Clinuvel Pharmaceuticals Ltd (CUVL) Transcripts
- 1